What theyre saying: We believe that inhibiting new pathways on top of GLP-1 receptor agonism has the potential to achieve comparable overall reductions in body weight, but with improved quality of a weight loss, resulting in more fat loss while preserving or actually increasing muscle mass. Regenerons CSO George Yancopoulos The big picture If any of these medications (or combinations of medications) can actually enable people to lose weight while preserving muscle mass, the impact on public health could be huge but itll likely be years before they reach the market
Also be aware of long-term safety questions and make sure your provider is monitoring you carefully
[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Xu C., Sun S., Johnson T., Qi R., Zhang S., Zhang J., Yang K
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, mimics a hormone in your gut that regulates appetite and digestion
At ThinEra, structured ongoing physician oversight is central to safe and effective GLP-1 weight loss